Joris M van Montfrans (Joris van Montfrans)

Years Active: 2019-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Amir Abdelmoumen, Joris M van Montfrans, Femke Van Wijk, Helen L Leavis
JAK Inhibition with Baricitinib for Severe CVID-Related Enteropathy: a Case Report. Journal of clinical immunology (2023)
Marie Valérie E Andriessen, G Elizabeth Legger, Robbert G M Bredius, Marielle E van Gijn, A Elisabeth Hak, Petra C E Hissink Muller, Sylvia Kamphuis, Femke C C Klouwer, Taco W Kuijpers, Helen L Leavis, Stefan Nierkens, Abraham Rutgers, Lars T van der Veken, Gijs T J van Well, Catharina M Mulders-Manders, Joris M van Montfrans
Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort. Journal of clinical immunology (2023)
Hemmo A F Yska, Kim Elsink, Taco W Kuijpers, Geert W J Frederix, Mariëlle E van Gijn, Joris M van Montfrans
Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review. Journal of clinical immunology 39 (6) (2019)

Joris M van Montfrans.css-eqlu8i{font-size:small;padding-left:4px;} (Joris van Montfrans)